Synereca Pharmaceuticals' Convertible Note Round

Synereca Pharmaceuticals raised a round of funding on September 16, 2014.

Synereca Pharmaceuticals was created to address the growing problem of bacterial resistance to current antibiotics by developing orally active drugs that restore or increase the effectiveness of exist…

Articles about Synereca Pharmaceuticals' Convertible Note Round: